# FDA 483 - Amandeep Salhotra, M.D. - December 04, 2025

Source: https://www.keypedia.com/records/483/amandeep-salhotra-md/52024809-e86d-4a76-9194-df3ab9d1f850

> FDA 483 for Amandeep Salhotra, M.D. on December 04, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Amandeep Salhotra, M.D.
- Inspection Date: 2025-12-04
- Product Type: drugs
- Office Name: Los Angeles District Office
- Summary: An FDA inspection of Amandeep Salhotra, M.D., a clinical investigator in Duarte, CA, revealed a significant deficiency in the conduct of an investigation. The firm failed to report serious adverse events to the sponsor within 24 hours, as mandated by the study protocol. This indicates a failure to adhere to the investigational plan and investigator responsibilities.

## Related Officers

- [Jasmine Y. Wang](https://www.keypedia.com/people/jasmine-y-wang/e23c7335-477c-4671-8dcc-72e9149d424e)

Company: https://www.keypedia.com/companies/amandeep-salhotra-md/2548bc0b-3691-423f-b027-a2bbbd3e0cdb

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b